Head-to-head · WeighScore
RxSpan MD vs ShedRx
The verdict
ShedRx takes it — 87/100 to 84.3/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | RxSpan MD | ShedRx |
|---|---|---|
| WeighScore | 84.3/100 | 87/100 |
| Grade | B | B+ |
| Site position | #6 | #3 |
| Semaglutide | $249/mo month-to-month ($219 on three months, $199 on six, $194 on twelve) | $199/mo |
| Tirzepatide | $329/mo month-to-month ($309 on three months, $289 on six, $269 on twelve) | $299/mo |
| Coverage | Confirm treatment availability during intake | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #6 · B
Strengths
- Public catalog offers compounded injections, oral options and brand-name programs
- Regular monthly injection pricing of $249 semaglutide and $329 tirzepatide
- Catalog states consultation, medication, supplies, shipping and support are included
- Names physician founder Dr. John Diaz and describes licensed-physician review
Where it loses points
- Lowest advertised monthly equivalents require prepaid terms and a promotional code
- Annual promotions automatically renew
- Public terms do not establish a refund schedule for unused prepaid treatment
- Compounded semaglutide and tirzepatide are not FDA-approved
Site position #3 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
Where it loses points
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Featured provider
ShedRx
ShedRx scores 87/100 (B+). The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.